iconEarnings Announcement Before Market Open

Moderna Inc MRNA:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:08 AM EDT
164.32quote price arrow up+1.48 (+0.91%)
Volume
14,607
Close
162.84quote price arrow down-10.75 (-6.19%)
Volume
18,071,951
52 week range
46.13 - 189.26

...

Loading . . .
  • Open178.10
  • Day High180.70
  • Day Low156.81
  • Prev Close162.84
  • 52 Week High189.26
  • 52 Week High Date02/08/21
  • 52 Week Low46.13
  • 52 Week Low Date05/27/20

Key Stats

  • Market Cap65.165B
  • Shares Out400.18M
  • 10 Day Average Volume11.90M
  • Dividend-
  • Dividend Yield-
  • Beta1.48
  • YTD % Change55.87

KEY STATS

  • Open178.10
  • Day High180.70
  • Day Low156.81
  • Prev Close162.84
  • 52 Week High189.26
  • 52 Week High Date02/08/21
  • 52 Week Low46.13
  • 52 Week Low Date05/27/20
  • Market Cap65.165B
  • Shares Out400.18M
  • 10 Day Average Volume11.90M
  • Dividend-
  • Dividend Yield-
  • Beta1.48
  • YTD % Change55.87

RATIOS/PROFITABILITY

  • EPS (TTM)-1.94
  • P/E (TTM)-84.06
  • Fwd P/E (NTM)7.22
  • EBITDA (MRQ)-731.893M
  • ROE (MRQ)-39.99%
  • Revenue (MRQ)803.40M
  • Gross Margin (MRQ)70.05%
  • Net Margin (MRQ)-92.99%
  • Debt To Equity (MRQ)5.24%

EVENTS

  • Earnings Date05/06/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Related Video

VIDEO0:5400:54
Biden administration supports waiver of patent protections for Covid vaccines

Profile

MORE
Moderna, Inc. is engaged in transformative medicines based on messenger ribonucleic acid (mRNA). It has created a platform to improve the underlying pharmaceutical properties of our mRNA medicines. Its platform consists of three areas: mRNA technologies, delivery technologies, and manufacturing processes. It is pursuing mRNA science to minimize the undesirable activation of the immune system by mRNA and to maximize the potency of mRNA once in the target cells. It has advanced...
Noubar Afeyan Ph.D.
Non-Executive Chairman
Stephane Bancel
Chief Executive Officer
Stephen Hoge M.D.
President
David Meline
Chief Financial Officer
Juan Andres
Chief Technology Officer
Lori Henderson J.D.
General Counsel
Address
200 Technology Sq
Cambridge, MA
02139-3578
United States

Top Peers

SYMBOLLASTCHG%CHG
BNTX
BioNTech SE
170.77-6.11-3.45%
ILMN
Illumina Inc
378.35-0.02-0.01%
GMAB
Genmab A/S
36.68+1.09+3.06%
EXAS
Exact Sciences Corp
110.65-5.37-4.63%
SGEN
Seagen Inc
135.08-1.11-0.81%